QA: Palvella Therapeutics INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001583648_2024_Palvella_Therapeutics_INC.pdf

Logs

Graph

Absolute values for 0001583648, Palvella Therapeutics INC

  xvar xval
0 AssetsCurrent 38,680,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 11,922,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 16,949,836
9 ResearchAndDevelopmentExpense 41,984,471
10 remainder_Expenses 8,443,881
11 remainder_Revenues 38,202,282
12 remainder_NetIncome 6,214,189
13 remainder_ComprehensiveNetIncome -223,552
  yvar yval
0 Assets 38,680,000
1 Liabilities 11,922,000
2 Expenses 67,378,188
3 Revenues 38,202,282
4 StockholdersEquity 26,758,000
5 NetIncome -22,961,717
6 ComprehensiveNetIncome -23,073,493
7 BaseVar 81,310,106
8 EconomicCapitalRatiobeforeLimitedLiability 1.39
9 EconomicCapitalRatio 2.60

Edgar->Model Mapping

Feature Distribution

Change over Time